Javascript must be enabled to continue!
An insertion mutation of the MECP2 gene in severe neonatal encephalopathy and ocular and oropharyngeal dyskinesia: a case report
View through CrossRef
Abstract
Background
Pathogenic variation of the MECP2 gene presents mostly as Rett syndrome in females and is extremely rare in males. Most male patients with MECP2 gene mutation show MECP2 duplication syndrome.
Case presentation
Here we report a rare case in a 10-month-old boy with a hemizygous insertion mutation in MECP2 as NM_001110792, c.799_c.800insAGGAAGC, which results in a frameshift mutation (p.R267fs*6). The patient presented with severe encephalopathy in the neonatal period, accompanied by severe development backwardness, hypotonia, and ocular and oropharyngeal dyskinesia. This is the first report of this mutation, which highlights the phenotype variability associated with MECP2 variants.
Conclusions
This case helps to expand the clinical spectrum associated with MECP2 variants. Close attention should be paid to the growth and development of patients carrying a MECP2 variant or Xq28 duplication. Early interventions may help improve symptoms to some certain extent.
Springer Science and Business Media LLC
Title: An insertion mutation of the MECP2 gene in severe neonatal encephalopathy and ocular and oropharyngeal dyskinesia: a case report
Description:
Abstract
Background
Pathogenic variation of the MECP2 gene presents mostly as Rett syndrome in females and is extremely rare in males.
Most male patients with MECP2 gene mutation show MECP2 duplication syndrome.
Case presentation
Here we report a rare case in a 10-month-old boy with a hemizygous insertion mutation in MECP2 as NM_001110792, c.
799_c.
800insAGGAAGC, which results in a frameshift mutation (p.
R267fs*6).
The patient presented with severe encephalopathy in the neonatal period, accompanied by severe development backwardness, hypotonia, and ocular and oropharyngeal dyskinesia.
This is the first report of this mutation, which highlights the phenotype variability associated with MECP2 variants.
Conclusions
This case helps to expand the clinical spectrum associated with MECP2 variants.
Close attention should be paid to the growth and development of patients carrying a MECP2 variant or Xq28 duplication.
Early interventions may help improve symptoms to some certain extent.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Dose-dependent nuclear delivery and transcriptional repression with a cell-penetrant MeCP2
Dose-dependent nuclear delivery and transcriptional repression with a cell-penetrant MeCP2
Abstract
Methyl-CpG-binding-protein 2 (MeCP2) is a nuclear protein expressed in all cell types, especially neurons
1
...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Etude des déficits catécholaminergiques centraux chez la souris Mecp2-déficiente, modèle murin du syndrome de Rett
Etude des déficits catécholaminergiques centraux chez la souris Mecp2-déficiente, modèle murin du syndrome de Rett
La méthylation de l’ADN est une modification majeure du génome des eucaryotes permettant de moduler l’expression génique et contrôler le développement des mammifères. La protéine M...
Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain
Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain
AbstractMeCP2 is an abundant protein, involved in transcriptional repression by binding to CG and non-CG methylated DNA. However, MeCP2 might also function as a transcription activ...
Mecp2 Fine-tunes Quiescence Exit by Targeting Nuclear Receptors
Mecp2 Fine-tunes Quiescence Exit by Targeting Nuclear Receptors
Abstract
Quiescence (G0) maintenance and exit are crucial for tissue homeostasis and regeneration in mammals. Here, we show that methyl-CpG binding protein 2 (Mecp2) expression is ...
Integrative analyses of transcriptome and DNA methylome from human neurons expressing multiple MECP2 levels
Integrative analyses of transcriptome and DNA methylome from human neurons expressing multiple MECP2 levels
Rett Syndrome (RTT) is a monogenic disorder, which mainly affects girls and is caused by mutations in methyl-CpG- binding protein 2 (MECP2). It is characterized by symptoms like lo...
MeCP2 controls dendritic morphogenesis via miR-199a-mediated Qki downregulation
MeCP2 controls dendritic morphogenesis via miR-199a-mediated Qki downregulation
Abstract
Rett syndrome (RTT) (OMIM: 312750) is a severe neurodevelopmental disorder caused by mutations in the
MECP2
...

